Having trouble accessing articles? Reset your cache.

TNFR2 and IL-33 identified as targets in Dupuytren's disease

DISEASE CATEGORY: Musculoskeletal

INDICATION: Dupuytren's disease

Inhibiting TNFR2 and IL-33 could treat Dupuytren's disease, which is characterized by progressive fibrosis of the palmar and digital fascia. The

Read the full 257 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE